USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 181 filers reported holding USANA HEALTH SCIENCES INC in Q3 2021. The put-call ratio across all filers is 2.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | -22.2% | 0 | -100.0% | 0.00% | – |
| Q2 2022 | $18,000 | -10.0% | 252 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -23.1% | 252 | 0.0% | 0.00% | – |
| Q4 2021 | $26,000 | +13.0% | 252 | 0.0% | 0.00% | – |
| Q3 2021 | $23,000 | -11.5% | 252 | 0.0% | 0.00% | – |
| Q2 2021 | $26,000 | +4.0% | 252 | 0.0% | 0.00% | – |
| Q1 2021 | $25,000 | -13.8% | 252 | -32.1% | 0.00% | – |
| Q4 2020 | $29,000 | +7.4% | 371 | 0.0% | 0.00% | – |
| Q3 2020 | $27,000 | +35.0% | 371 | +38.4% | 0.00% | – |
| Q2 2020 | $20,000 | -75.6% | 268 | -61.7% | 0.00% | – |
| Q4 2018 | $82,000 | +9.3% | 700 | +12.5% | 0.00% | – |
| Q3 2018 | $75,000 | -9.6% | 622 | -13.9% | 0.00% | – |
| Q2 2018 | $83,000 | -36.6% | 722 | -52.6% | 0.00% | – |
| Q1 2018 | $131,000 | -56.0% | 1,522 | -62.2% | 0.00% | -100.0% |
| Q4 2017 | $298,000 | – | 4,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |